Here are some competitors in the c diff space.... some could see this as positive because the mechanisms are different and highlights need for prevention and treatment.... some will see this as another company already having approval where IMC are still in early trials.....
https://www.biopharmadive.com/news/fda-rebiotix-microbiome-c-diff-advisers-committee-vote/632489/
Here are some competitors in the c diff space.... some could see...
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.79M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 51067 | 1 |
View Market Depth
| Last trade - 16.12pm 03/10/2024 (20 minute delay) ? |
| IMC (ASX) Chart |
Day chart unavailable